Renal Denervation Therapy: Indications and Success Factors. (26th May 2013)

• Record Type: Journal Article
• Authors: Stangl, Karl; Stangl, Verena; Schwerg, Marius; Searle, Julia; Möckel, Martin
• Other Names: Bellou Abdelouahab Academic Editor.; Giannitsis Evangelos Academic Editor.; Hamm Christian Academic Editor.
• Is Part Of: Conference papers in energy. Volume 2013(2013)
• Publication Date: 2013-05-26
• Subjects: Power resources -- Periodicals; Power resources; Periodicals; Electronic journals; 333.79
• DOI: 10.1155/2013/804764
• Languages: English
• ISSNs: 2314-582X

Abstract

Abstract : Arterial hypertension is a common and an increasing health care problem. In Germany and other Western countries, prevalence rates are as high as 50%. Of these, 13% of patients suffer from refractory hypertension, where the target blood pressure is not achievable with >3 antihypertensive substances. Renal denervation therapy (RDT) is a relatively new, catheterization-based intervention to treat patients with refractory hypertension. The rationale of RDT is the mechanical destruction with high frequency ablation of renal sympathetic fibers, which can be easily accessed via the renal artery. The first clinical trials evaluating effect and safety of the procedure have been promising, and RDT is being routinely used in specialized centers.